Hormone Therapy With or Without Docetaxel And Estramustine in Treating Patients With Prostate Cancer That is Locally Advanced or At High Risk of Relapse
This study is ongoing, but not recruiting participants.
Study NCT00055731
Information provided by National Cancer Institute (NCI)
First Received: March 6, 2003
Last Updated: October 6, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
